01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

permeability factor/vascular endothelial factor in human
hepatocellular carcinoma. Cancer Res 56, 3004-3009.
Svensson U and Persson R (1984) Entry of adenovirus 2 into
HeLa cells. J Virol 51, 687-694.
Swantek JL, Cobb MH, Geppert TD (1997) Jun N-terminal
kinase/stress-activated protein kinase (JNK/SAPK) is
required for lipopolysaccharide stimulation of tumor necrosis
factor α (TNF-α) translation: glucocorticoids inhibit TNF-α
translation by blocking JNK/SAPK. Mol Cell Biol 17, 6274-
6282.
Szary J, Missol E, Tarnawski R, Szala S (1997) Selective
augmentation of radiation effects by 5-fluorocytosine on
murine B16(F10) melanoma cells transfected with cytosine
deaminase gene. Cancer Gene Ther 4, 269-272.
Szostak, J.W., Orr-Weaver, T.L., Rothstein, R.J. and Stahl, F.W.
(1983) The double-strand-break repair model for
recombination. Cell 33, 25-35.
Tahara H, Lotze MT, Robbins PD, Storkus WJ, Zitvogel L
(1995) IL-12 gene therapy using direct injection of tumors
with genetically engineered autologous fibroblasts. Hum
Gene Ther 6, 1607-1624.
Tahara H, Zitvogel L, Storkus WJ, Robbins PD, Lotze MT
(1996) Murine models of cancer cytokine gene therapy using
interleukin-12. Ann N Y Acad Sci 795, 275-283.
Takahashi JC, Saiki M, Miyatake S, Tani S, Kubo H, Goto K,
Aoki T, Takahashi JA, Nagata I, Kikuchi H (1997)
Adenovirus-mediated gene transfer of basic fibroblast
growth factor induces in vitro angiogenesis. Atherosclerosis
132, 199-205.
Takahashi T, Nau MM, Chiba I, Birrer MJ, Rosenberg RK,
Vinocour M, Levitt M, Pass H, Gazdar AF, Minna JD (1989)
p53: A frequent target for genetic abnormalities in lung
cancer. Science 246: 491-494.
Takehara T, Hayashi N, Yamamoto M, Miyamoto Y, Fusamoto
H, Kamada T (1996) In vivo gene transfer and expression in
rat stomach by submucosal injection of plasmid DNA. Hum
Gene Ther 7, 589-593.
Takeshita S, Isshiki T, Mori H, Tanaka E, Tanaka A, Umetani K,
Eto K, Miyazawa Y, Ochiai M, Sato T (1997)
Microangiographic assessment of collateral vessel formation
following direct gene transfer of vascular endothelial growth
factor in rats. Cardiovasc Res 35, 547-552.
Takeshita S, Losordo DW, Kearney M, Rossow ST, and Isner
JM (1994b) Time course of recombinant protein secretion
after liposome-mediated gene transfer in a rabbit arterial
organ culture model. Lab Invest 71, 387-391.
Takeshita S, Zheng LP, Brogi E, Kearney M, Pu L-Q, Bunting S,
Ferrara N, Symes JF, and Isner JM (1994a) Therapeutic
angiogenesis. A single intraarterial bolus of vascular
endothelial growth factor augments revascularization in a
rabbit ischemic limb model. J Clin Invest 93, 662-670.
Takle GB, Thierry AR, Flynn SM, Peng B, White L, Devonish
W, Galbraith RA, Goldberg AR, George ST (1997) Delivery
of oligoribonucleotides to human hepatoma cells using
cationic lipid particles conjugated to ferric protoporphyrin IX
(heme). Antisense Nucleic Acid Drug Dev 7, 177-185.
Tamayose K, Hirai Y, Shimada T (1996) A new strategy for
large-scale preparation of high-titer recombinant adeno-
Boulikas: An overview on gene therapy
158
associated virus vectors by using packaging cell lines and
sulfonated cellulose column chromatography. Hum Gene
Ther 7, 507-513.
Tamura H, Schild L, Enomoto N, Matsui N, Marumo F, Rossier
BC (1996) Liddle disease caused by a missense mutation of
β subunit of the epithelial sodium channel gene. J Clin
Invest 97, 1780-1784.
Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J,
Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, et
al (1995) Identification and expression cloning of a leptin
receptor, OB-R. Cell 83, 1263-1271.
Tatulain SA, Hinterdorfer P, Baber G, Tamm LK (1995)
Influenza hemagglutinin assumes a tilted conformation
during membrane fusion as determined by attenuated total
reflection FTIR spectroscopy. EMBO J 14, 5514-5523.
Templeton NS, Lasic DD, Frederik PM, Strey HH, Roberts DD,
Pavlakis GN (1997) Improved DNA: liposome complexes
for increased systemic delivery and gene expression. Nat
Biotechnol 15, 647-652.
Tepper RI, Pattengale PK, Leder P (1989) Murine Interleukin-4
displays potent anti-tumor activity in vitro. Cell 57, 503-512.
Thierry AR and Dritschilo A (1992) Intracellular availability of
unmodified, phosphorothioated and liposomally encapsulated
oligodeoxynucleotides for antisense activity. Nucleic Acids
Res 20, 5691-5698.
Thierry AR, Lunardi-Iskandar Y, Bryant JL, Rabinovitch P,
Gallo RC, and Mahan LC (1995) Systemic gene therapy:
biodistribution and long-term expression of a transgene in
mice. Proc Natl Acad Sci USA 92, 9742-9746.
Thompson L (1992) At age 2, gene therapy enters a growth
phase. Science 258, 744-746.
Thompson, E.M., Christians, E., Stinnakre, M.G., and Renard,
J.P. (1994) Scaffold attachment regions stimulate HSP70.1
expression in mouse preimplantation embryos but not in
differentiated tissues. Mol Cell Biol 14, 4694-4703.
Thut CJ, Chen J-L, Klemm R, and Tjian R (1995) p53
transcriptional activation mediated by coactivators TAFII40
and TAFII60. Science 267, 100-104.
Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D,
Fiddes JC, and Abraham JA (1991) The human gene for
vascular endothelial growth factor. Multiple protein forms
are encoded through alternative exon splicing. J Biol Chem
266, 11947-11954.
Tomita N, Morishita R, Higaki J, Aoki M, Nakamura Y, Mikami
H, Fukamizu A, Murakami K, Kaneda Y, Ogihara T (1995)
Transient decrease in high blood pressure by in vivo transfer
of antisense oligodeoxynucleotides against rat
angiotensinogen. Hypertension 26, 131-136.
Tomita N, Morishita R, Higaki J, Tomita S, Aoki M, Ogihara T,
Kaneda Y (1996) In vivo gene transfer of insulin gene into
neonatal rats by the HVJ-liposome method resulted in
sustained transgene expression. Gene Ther 3, 477-482.
Troelstra C, van Gool A, de Wit J, Vermeulen W, Bootsma D
and Hoeijmakers JHJ (1992) ERCC6, a member of a
subfamily of putative helicases, is involved in Cockayne's
syndrome and preferential repair of active genes. Cell 71,
939-953.